Zobrazeno 51 - 60
of 305
pro vyhledávání: '"Guy De Backer"'
Autor:
Ian, Graham, Chuck, Shear, Pieter, De Graeff, Caroline, Boulton, Alberico L, Catapano, Wendy Gattis, Stough, Stefan C, Carlsson, Guy, De Backer, Joseph, Emmerich, Scott, Greenfeder, Albert M, Kim, Dominik, Lautsch, Tu, Nguyen, Steven E, Nissen, Krishna, Prasad, Kausik K, Ray, Jennifer G, Robinson, William J, Sasiela, Karsten, Bruins Slot, Erik, Stroes, Tom, Thuren, Bart, Van der Schueren, Maja, Velkovski-Rouyer, Scott M, Wasserman, Olov, Wiklund, Emmanouil, Zouridakis, Cathrine, Thorstensen
Publikováno v:
European heart journal. Cardiovascular pharmacotherapy, 4(2). Oxford University Press
The very high occurrence of cardiovascular events presents a major public health issue because treatment remains suboptimal. Lowering low-density lipoprotein cholesterol (LDL-C) with statins or ezetimibe in combination with a statin reduces major adv
Autor:
Eliseo Guallar, José R. Banegas, Carine Roy, Julian Halcox, Joep Perk, Jean Dallongeville, Florence Tubach, Claudio Borghi, Guy De Backer, Javier Nuevo, Fernando Rodríguez-Artalejo, Jesús Medina
Background Reports are conflicting on whether serum uric acid (sUA) levels are independently associated with increased cardiovascular (CV) death risk. Methods This post hoc analysis assessed the relationship between sUA levels and CV death risk score
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21570af44e936daec84afc91137bfded
https://cronfa.swan.ac.uk/Record/cronfa37931/Download/0037931-12012018082853.pdf
https://cronfa.swan.ac.uk/Record/cronfa37931/Download/0037931-12012018082853.pdf
Autor:
Renata Cifkova, Žjelko Reiner, Viveca Gyberg, Lieven Annemans, David R. Wood, Nana Pogosova, Jan Bruthans, Phillippe Amouyel, Aleksandras Laucevičius, Marina Dolzhenko, Lars Rydén, Dirk De Bacquer, Delphine De Smedt, Rafael G. Oganov, Guy De Backer, Nina Gotcheva, Andrzej Pajak, Andrejs Erglis, Dragan Lovic, Johan De Sutter, Martin Stagmo, Kornelia Kotseva
Publikováno v:
International Journal of Cardiology
Volume 272
Volume 272
Background: This study aims to assess the cost-effectiveness of optimized guideline adherence in patients with a history of coronary heart disease. Methods: An individual-based decision tree model was developed using the SMART risk score tool which e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::868a86aa7f269be1f7708fd3553a1ff9
https://ruj.uj.edu.pl/xmlui/handle/item/108775
https://ruj.uj.edu.pl/xmlui/handle/item/108775
Autor:
Michael Roden, Alberico L. Catapano, Erik S.G. Stroes, Georgirene D. Vladutiu, Børge G. Nordestgaard, Baris Gencer, Paul D. Thompson, Robert A. Hegele, Henry N. Ginsberg, Jane K Stock, G. Kees Hovingh, Alberto Corsini, Raul D. Santos, Winfried März, Ulrich Laufs, Lawrence A. Leiter, Lale Tokgozoglu, Eric Bruckert, Terry A. Jacobson, Kausik K. Ray, Guy De Backer, François Mach, M. John Chapman, Olov Wiklund, Ronald M. Krauss, Frederick J. Raal, Evan A. Stein
Publikováno v:
European Atherosclerosis Society Consensus Panel 2018, ' Adverse effects of statin therapy : perception vs. the evidence-focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract ', European Heart Journal, vol. 39, no. 27, pp. 2526-2539 . https://doi.org/10.1093/eurheartj/ehy182
European heart journal, vol 39, iss 27
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
European Heart Journal
European heart journal, vol 39, iss 27
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
European Heart Journal
Aims: To objectively appraise evidence for possible adverse effects of long-term statin therapy on glucose homeostasis, cognitive, renal and hepatic function, and risk for haemorrhagic stroke or cataract.Methods and results: A literature search cover
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82f6e225d2d07a2b232702705a629dc0
https://curis.ku.dk/portal/da/publications/adverse-effects-of-statin-therapy(b2d7cbca-5095-4c15-87bc-17a79ace9147).html
https://curis.ku.dk/portal/da/publications/adverse-effects-of-statin-therapy(b2d7cbca-5095-4c15-87bc-17a79ace9147).html
Publikováno v:
European Heart Journal. 36:950-955
Autor:
Peter R, Sinnaeve, Walter, Desmet, Olivier, Descamps, Sofie, Gevaert, Guy, De Backer, Philippe, Kolh, Mathias, Vrolix, Philippe, Van De Borne, Antoine, De Meester, Marc J, Claeys, Christophe, Beauloye
Publikováno v:
Acta cardiologica. 72(1)
Acute coronary syndrome patients receive DAPT up to one year after their initial event. Exceptions to the guideline-recommended one-year rule, however, are not uncommon. The reasoning behind shorter treatments, such as unacceptable bleeding risk or u
Autor:
Jaakko Tuomilehto, David R. Wood, Kornelia Kotseva, Viveca Gyberg, Linda Mellbin, Dirk De Bacquer, Guy De Backer, Oliver Schnell, Bahira Shahim, Lars Rydén
OBJECTIVE Three tests are recommended for identifying dysglycemia: fasting glucose (FPG), 2-h postload glucose (2h-PG) from an oral glucose tolerance test (OGTT), and glycated hemoglobin A1c (HbA1c). This study explored the prognostic value of these
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a15203084eabc68335f9b9dfd066c14
http://hdl.handle.net/10044/1/54688
http://hdl.handle.net/10044/1/54688
Autor:
Bahira, Shahim, Dirk, De Bacquer, Guy, De Backer, Viveca, Gyberg, Kornelia, Kotseva, Linda, Mellbin, Oliver, Schnell, Jaakko, Tuomilehto, David, Wood, Lars, Rydén
Publikováno v:
Diabetes Care
OBJECTIVE Three tests are recommended for identifying dysglycemia: fasting glucose (FPG), 2-h postload glucose (2h-PG) from an oral glucose tolerance test (OGTT), and glycated hemoglobin A1c (HbA1c). This study explored the prognostic value of these
Autor:
Guy, De Backer
Publikováno v:
European journal of preventive cardiology. 24(7)
With observational epidemiological studies it has been possible in the 1950-60 s to identify what has been called cardiovascular risk factors. The multifactorial origin of atherothrombotic cardiovascular disease has been elucidated and in multifactor
Autor:
José R. Banegas, Eliseo Guallar, Julian Halcox, Jean Dallongeville, Joep Perk, Claudio Borghi, David Hajage, Karin M. Henriksson, Guy De Backer, Carine Roy
Publikováno v:
BMC Cardiovascular Disorders, Vol 17, Iss 1, Pp 1-11 (2017)
BMC Cardiovascular Disorders
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Biblos-e Archivo. Repositorio Institucional de la UAM
instname
BMC Cardiovascular Disorders
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Biblos-e Archivo. Repositorio Institucional de la UAM
instname
Background: Atherogenic dyslipidemia is associated with poor cardiovascular outcomes, yet markers of this condition are often ignored in clinical practice. Here, we address a clear evidence gap by assessing the prevalence and treatment of two markers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed25f59edb4901026a5e73638feae360
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-329663
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-329663